Winner
EVA - Expert VOD Assistant
Summary of work
Veno-occlusive disease (VOD) is a rare, potentially fatal liver complication following haematopoietic stem cell transplantation. When Jazz Pharmaceuticals reduced its Defitelio field force, transplant specialists lost the educational resource they'd relied on for complex clinical questions.
The pharma industry had tried chatbots before. Without exception, they were glorified FAQs. And genuinely conversational AI had never been deployed within pharma compliance frameworks, because the core tension seemed unresolvable: clinicians need to ask open, messy, real questions, but every answer must come from approved content.
EVA (Expert VOD Assistant) solved that tension. Using novel AI technologies, EVA lets specialists ask whatever they want while ensuring every response is assembled from over 250 pre-approved answers, delivered through a lifelike AI avatar that feels like talking to a knowledgeable colleague.
At EBMT 2025, 76 specialists interacted with EVA (152% of target), asking 140 clinical questions across four-minute average interactions. Eighty-three per cent rated her educational value as very or extremely valuable, and 30% said they'd adjust their clinical practice as a result. Those 140 questions also revealed what clinicians are genuinely uncertain about – insight now shaping future VOD education.
Judges’ comments
The judges were really impressed by Camino and Jazz Pharmaceuticals’ entry. It was a great example of using AI in a meaningful way. It was exciting, ticked a lot of boxes for engagement and was transparent. Plus the judges could see how it could be scalable in the future. It was technically strong.
